Viewing Study NCT05081492


Ignite Creation Date: 2025-12-24 @ 3:44 PM
Ignite Modification Date: 2026-01-05 @ 5:22 PM
Study NCT ID: NCT05081492
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-06
First Post: 2021-10-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer
Sponsor: City of Hope Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anatomic Stage IV Breast Cancer AJCC v8 View
None Metastatic Triple-Negative Breast Carcinoma View
None Prognostic Stage IV Breast Cancer AJCC v8 View
Keywords: